Marianne van Vugt

Literature Mining for the Discovery of Hidden Connections between Drugs, Genes and Diseases

Raoul Frijters, Marianne van Vugt, Ruben L. Smeets et al. · PLoS Computational Biology · 2010 · 163 citations · Full text

Medicine, Bioinformatics, Biomedical Text Mining +14

Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects

Anthe S. Zandvliet, Shirley Glasgow, Ann D. Horowitz et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 22 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetics and Pharmacodynamics of the <scp>BACE</scp>1 Inhibitor Verubecestat (<scp>MK</scp>‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

K. Chris Min, Marissa F. Dockendorf, John Palcza et al. · Clinical Pharmacology & Therapeutics · 2018 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

Medicine, Immunology, Oncology +17

Immunogenicity of pembrolizumab (pembro) in patients (pts) with advanced melanoma (MEL) and non-small cell lung cancer (NSCLC): Pooled results from KEYNOTE-001, 002, 006, and 010.

Marianne van Vugt, Rik de Greef, Tomoko Freshwater et al. · Journal of Clinical Oncology · 2016 · 11 citations

Medicine, Oncology, Pharmacology +17